w w w . e l s e v ie r . c o m / l o c a t e / b j i d
The
Brazilian
Journal
of
INFECTIOUS
DISEASES
Review
article
Efficacy
and
safety
of
dimeticones
in
the
treatment
of
epidermal
parasitic
skin
diseases
with
special
emphasis
on
tungiasis:
an
evidence-based
critical
review
夽
Hollman
Miller
a,1,
Julián
Trujillo-Trujillo
b,∗,1,
Francis
Mutebi
c,1,
Hermann
Feldmeier
d,1aSecretaríadeSaluddeVaupés,Mitú,Colombia
bMinistryofHealthandSocialProtection,Bogota,Colombia
cMakerereUniversity,AnimalResourcesandBiosecurity,CollegeofVeterinaryMedicine,Kampala,Uganda dCharitéUniversityMedicine,InstituteofMicrobiologyandInfectionImmunology,Berlin,Germany
a
r
t
i
c
l
e
i
n
f
o
Articlehistory:
Received4October2019 Accepted27January2020 Availableonline24February2020
Keywords:
Tungiasis
Pediculosistreatment Sandfleadisease Dimeticone
Indigenouspopulations Indigenouspopulationsdiseases
a
b
s
t
r
a
c
t
Epidermalparasiticskindiseasesencompassscabies,pediculosis,cutaneouslarvamigrans, myiasis,andtungiasis.TungiasisisprobablythemostneglectedofallNeglectedTropical Diseases(NTD).ItoccursinSouthAmerica,theCaribbeanandSub-SaharanAfricaand affectsmarginalizedpopulationswherepeopleliveinextremepoverty.Inendemic com-munitiestheprevalencecanbeupto30%ingeneralpopulationand85%inchildren.Over time,chronicpathologydevelopscharacterizedbyhyperkeratosis,edemaaroundthenail rim,fissures,ulcers,deformationandlossofnails.Thisleadstoapatternofdisabilities, eventuallyresultinginimpairmentofmobility.
Dimeticonesareafamilyofsiliconoilswithapotentialtokillparasiteslocatedontop orinsidetheepidermisbyaphysicalmodeofaction.Theyareconsideredthetreatmentof choiceforpediculosiscapitisandpediculosispubis.Withregardtotungiasis,thesocalled rearabdominalconeoftheparasiteshasbeenidentifiedasa targetfortreatmentwith dimeticones.NYDA®,amixtureoftwodimeticoneswithdifferentviscosity,istheonly dimeticoneproductforwhichdataonthemodeofaction,efficacyandsafetywithregardto tungiasisexists.Theproducthasbeenshownhighlyeffectiveagainstembeddedsandfleas, eveninveryintenseinfectionwithmorethan500parasitessituatedontopofeachother.A randomizedcontrolledtrialshowedthatsevendaysafteratargetedapplicationofNYDA® 97%(95%CI94–99%)oftheembeddedsandfleashadlostallsignsofviability.
夽ThefinancingofthisworkwasdonebytheCharitéUniversityofBerlin. ∗ Correspondingauthor.
E-mailaddress:trujillotrujillojulian@gmail.com(J.Trujillo-Trujillo).
1 Allauthorscontributedequallytothereviewoftheliterature,tothewritingandcriticalreviewofthemanuscript. https://doi.org/10.1016/j.bjid.2020.01.004
1413-8670/©2020SociedadeBrasileiradeInfectologia.PublishedbyElsevierEspa ˜na,S.L.U.ThisisanopenaccessarticleundertheCC BY-NC-NDlicense(http://creativecommons.org/licenses/by-nc-nd/4.0/).
Comprehensive toxicological investigations on the dimeticones contained in NYDA® showedthatthereispracticallynoriskofembryotoxicity,fetotoxicity,teratogenicity,and othertoxicity.Thesafetyofdimeticoneswasalsodemonstratedinclinicaltrialswithatotal of106participantswithtungiasis,inwhichnotasingleadverseeventwasobserved.
©2020SociedadeBrasileiradeInfectologia.PublishedbyElsevierEspa ˜na,S.L.U.Thisis anopenaccessarticleundertheCCBY-NC-NDlicense(http://creativecommons.org/ licenses/by-nc-nd/4.0/).
Introduction
Tungiasis(sandfleadisease)isaparasiticskindiseasewith originsintheAmericas.Amultitudeoflocaldesignations indi-catethattungiasisoriginallyoccurredinmostcountriesand populationsoftheAmericas.1Insomeareastungiasisisstill
socommonthatitbecamepartofthelocalfolklore(Fig.1). DataongeographicaldiseaseoccurrenceintheAmericasis scanty,butindicatethattungiasisexistsinMexico,Honduras,2
Venezuela, Colombia,3 Ecuador, Peru, Paraguay, Argentina,
Haiti,Barbados,andTrinidad.3,4InBraziltungiasisisreported
fromAmazoniaStateintheNorthtoRioGrandedoSulState intheSouth.5Severalcommunity-basedstudiesperformedin
Brazil,HaitiandTrinidad-Tobagoshowedastoundinglyhigh prevalencein resource-poorrural and urbancommunities.
Fig.1–NameplateofacoffeeshopinPopayan,Southwest Colombia,reflectingthattungiasiswascommoninthe town.NiguaisapopularnameinSpanishforthesandflea.
Prevalencerangedfrom10.6to82.6%inthegeneral popula-tion.
Tungiasis seems to be frequent in Amerindian popu-lations in the Amazon/Orinoco lowlands of Colombia and Venezuela. In Amerindian populations, tungiasis is asso-ciated with severe morbidity potentially leading to death (Heukelbach, unpublished observation, 2012; Grundmann, unpublishedobservations,2010;Roger,unpublished observa-tion,2017).Eveninchildren≤1yeartheprevalencewas2%.3
Howintensetransmissioncanbeinaresource-poorsetting isdemonstratedbyastudyinafavelainFortaleza,Northeast Brazil.Allindividualswhoenteredthecommunityafterbeing outoftheendemicareaforsometimebecameinfectedwithin threeweeks.Inthissettingtheaverageattackratewas15fleas perpersonperweek.6
Usually, transmission occurs peri-domiciliary. When housesdonothaveasolidfloor,anddomesticanimalscan roaminanout,intra-domiciliarytransmissionisfrequent.7–9
InAmerindiancommunities,commonlythewholelifecycle oftheparasiteiscompletedinsidethehouse.10
Morbidityistriggeredbyanintenseinflammatoryresponse around embedded female sand fleas11 leading to pain
and intense itching. Bacterial super-infection of lesions is almost constant and intensifies the inflammation.12
In non-immunized individuals, tetanus is a known fatal complication.13Overtime,withconstantre-infection,chronic
pathology developscharacterizedbyhyperkeratosis,edema aroundthenailrim,fissures,ulcers,deformationandlossof nails.Thisleadstoapatternofdisabilitiesfinallyresultingin partialortotalimmobility.14Children,personswith
disabili-tiesandtheelderlybearthehighestdiseaseburden.11,15
Theaimofthisreviewistocriticallyevaluatetheefficacy andsafetyofdimeticonesinthetreatmentoftungiasis.
Methodology
Studydesign
Initialsearchesrevealedthatpublishedstudiesonthe treat-mentoftungiasisvariedconsiderablyintermsofintervention types,outcomemeasures,durationoftreatmentandlength offollow-up,makingameta-analysisorasystematicreview unfeasible. Hence, a narrative-style review ofpublications, usingsystematicdatasearches,wasperformed.
Searchstrategies
Studiesevaluatingtheefficacyoftreatmentsagainsttungiasis werecollectedfromasetofdatabasesusingthespecificsearch
terms‘tungiasis’,‘Tunga*’,‘Tungapenetrans’,‘sandfleadisease’, ‘efficacy’and‘safety’.Thedatabasessearchedincluded MED-LINE, PubMed,SciELO and Lilacs.Databaseswere searched frominceptionto31December2018.
To identify studies not indexed in the databases listed above,greyliteraturewassearchedinOpenGreyandPQDT Global(ProQuestDissertations&ThesesGlobal).
Studyselection
Duetothesmallnumberofpublications,allstudies investi-gatingtheefficacyandsafetyofdimeticonesinthetreatment ofepidermalparasiticskindiseaseswereincluded,regardless ofstudy population, intervention type,outcome measures, durationoffollow-up,andlanguage.
Results
Variousinsecticides andanti-helminthicshave beentested regardingtheiractivity againstembeddedsand fleas,using systemicortopicalapplication. Inarandomizedcontrolled trial,theefficacyofthetopicalapplicationofivermectinlotion (0.8% w/v), metrifonate (trichlorfon) lotion (0.2% w/v), thi-abendazole lotion (0.2% w/v), thiabendazole ointment (5% w/v)were comparedtoplacebo lotion.16 Thestudyshowed
alighteffectofivermectinlotion,metrifonatelotionand thi-abendazolelotion.Arandomizedcontrolledstudywithoral ivermectindidnotshowanyeffectatall.17
Hitherto,onlyforonecommerciallyavailabledimeticone productdata onmode ofaction, efficacy against ectopara-sitesand safety isavailable. NYDA® (Pohl-BoskampGmbH &Co. KG,Hohenlockstedt,Germany) contains amixtureof twodimeticones differing inviscosity and volatility,which accountforthespecialcreepingandspreadingpropertiesof NYDA®.Thehigh-andthelow-viscousdimeticonesarethe functionalcomponentsresponsibleforthephysicalmodeof action.18,19NYDA® isacertifiedmedicaldeviceaccordingto
MedicalDeviceDirectiveinEurope.Itisregisteredforthe treat-mentofpediculosiscapitisinover30countriesworldwide.
NYDA® entersopenings as small as 10m and rapidly coversmicroscopicsurfaces.20 Thedimeticonewiththelow
viscosityevaporatesand thedimeticone withthehigh vis-cosityformsanoilfilmwhichclosestheopeningsandseals microscopicsurfaces.
NYDA® also contains medium-chain triglycerides and jojobaoil.Themedium-chaintriglyceridesandthejojobaoil are addedas hairand skinnourishingcomponents and to increasethecosmeticperformanceoftheformula.Theydo nothaveaneffectonectoparasites.18,19NYDA® doesnot
con-tainanycomponentwithaneurotoxicmodeofaction.
Modeofactionofdimeticones
Dimeticones(synonyms:polydimethylsiloxanes;siliconeoils) consist of fully methylated linear siloxane polymers con-taining repeating units of the formula [(CH3)2SiO] with trimethylsiloxyend-blockingunitsoftheformula.21Theyare
translucent,almostodorlessfluids.22
Fig.2–Sectionofafemalesandfleainstage3.The parasiteisalmostcompletelyembeddedintheskin.Itis obviousthattheparasiteisdifficulttotarget.
The mode ofaction ofdimeticones was investigatedin headlice(Pediculushumanuscapitis)andhousecrickets(Acheta
domestica). WhenNYDA® wasappliedontheabdomenand thoraxoftheinsects,thedimeticonerapidlyspreadoverthe chitinouscuticleoftheinsects,producingaclosedoillayer, and within1min,enteredtherespiratorytract throughthe 14stigmata(theentriestothetrachealsystem,locatedatthe lateralsideoftheinsect).20
Inhousecrickets,theinsect’sheadtracheawascompletely filledwithNYDA® withinlessthan1min;inheadlicethe fill-ing oftheentiretrachealsystemoccurredwithin3.5min.20
Thisresultedinblockingtheoxygensupplytothebrain. Since the cuticle of the blood-sucking insects becomes completely coveredwith afilmofthe high-viscous dimeti-cone,theyareunabletoeliminatethewatertheyhavetaken upwithabloodmeal,eventuallyleadingtodisruptionofthe intestine.18 Eithermodeofactionispurelyphysical.Similar
observationsweremadeinpiglice,parasitesthataremuch largerthanhumanlice17(MutebiFandFeldmeierH,
unpub-lishedobservation).
Itisdifficulttoenvisagehowaninsectcandevelop resis-tanceagainstacompoundwhichhasapurelyphysicalmode ofaction,particularlyiftheparasitesarekilledwithinavery shorttime.
Rationalefortheuseofdimeticonesintungiasis
Onceafemalesandfleahasbecomeembeddedintheskin (Fig.2),itremainsincontactwiththeenvironmentthrough atinyopeninginthecorneallayer(Figs.3and4).Inthe so-calledrearabdominalconewhichprotrudesabovetheskin, anumberofvitalorgansbegin/end,namelytherespiratory tract,theintestinaltractandthegenitaltract.Thediameter oftheopeningsoftherespectivetractsisnotpreciselyknown
Fig.3–Scanningelectronmicroscopyoftherearabdominal coneofanembeddedfemalesandfleaprotrudingabove theskin.Heretherespiratorytractbeginsandtheintestinal andthegenitaltractend.
Fig.4–PigidialareaandrespiratoryspiraclesofTunga Penetrans.
butisconsiderablylessthan20m.Onlyfluidswithnosurface tensioncanpenetrateintosuchsmallopenings.
ToconfirmthephysicalmodeofactionofNYDA® against embeddedsandfleas,astudyinnaturallyinfectedpigswas performedinUganda(MutebiFandFeldmeierH,unpublished observation).Fivedropsweretargetedtotherearabdominal coneofan embeddedsand flea.Theembeddedsand fleas wereremovedsurgicallyand wereexaminedusinga hand-heldlightmicroscopetoestablishifthedimeticonehascrept into the rear abdominal cone. In all cases the abdominal coneofembeddedsandfleaswassealedbythehighviscous dimeticoneandthephysicalmodeofactionofdimeticoneson embeddedsandfleaswasconfirmed(MutebiandFeldmeier, unpublishedobservation).
Efficacy
of
dimeticones
Efficacyinthetreatmentofpediculosis
Arandomized,controlled,observer-blindedclinicaltrialwas performedinapoorneighborhoodinBrazil.23Childrenaged
5–15yearswithahighintensityofinfestationwithheadlice weretreatedtwicewithNYDA® sevendaysapart.NYDA® was comparedtopermethrin1%,thelocalstandardtreatment.The scalpandthehairwerewettedwithNYDA® accordingtothe instructionsofthe producer.After8hthehairwaswashed withacommercialshampoonotcontainingdimeticones.A normalcombwasusedtospreadtheliquidsevenly.Overall curerateswere:day2(afterfirsttreatment)–dimeticone94.5% (95%CI:86.6–98.5%)andpermethrin66.7%(95%CI:54.6–77.3%;
p<0.0001);day9(aftersecondtreatment)–dimeticone97.2% (95%CI:90.3–99.7%)[p<0.0001]andpermethrin67.6%(95%CI: 55.4–78.2%)[p<0.0001].
In twoin vitro studies the efficacy ofNYDA® on killing headliceembryoswasinvestigatedusingaHairTuft Bioas-say.Afteranimmersionofviableheadliceeggsfor30minin NYDA®,noeggshatched.Iftheapplicationtimewasreduced to10min,5–8%oftheembryossurvivedanddevelopedinto adults.When9–11daysoldheadliceeggsweretreatedwith NYDA®,the efficacyofkillinglice embryoswasreducedto 97%.24,25
Anecdotal observations suggest that pubic lice are also highlysusceptibletotreatmentwithNYDA®.26
Efficacyinthetreatmentoftungiasis
The efficacy of NYDA® in the treatment of tungiasis was investigatedintworandomizedcontrolledstudiesperformed inKenyaandUganda,andinacaseseriesinpatientswith extremelyseveretungiasisinColombia.
Thetopicalapplication ofNYDA® tothewhole footfor 10minwascomparedtobathingthefootinKMnO4for10min
withsubsequentapplicationofpetroleumjelly.Thelatteris thestandardtreatmentrecommendedbytheMoHofKenya.15
Patients were monitored every second day for a total of 7 days.Outcome measures were disappearance ofviability signs (expulsion of eggs, excretion of fecal thread, excre-tionoffecalliquidorpulsations/contractionsoftheparasite) assessedthrough adigital handheldmicroscope,abnormal developmentregardingthelifestagesdefinedintheFortaleza classification11andassessmentofalocalinflammationscore.
Sevendaysaftertreatment,inthedimeticonegroup78% (95%CI67–86%)oftheparasiteshadlostallsignsofviability comparedto39%(95%CI28–52%) inthe KMnO4-petroleum
jellygroup(p<0.001).In thedimeticone group90%(95% CI 80–95%) ofthe penetrated sand fleas showed anabnormal developmentalreadyafterfivedays,comparedto53%(95%CI 40–66%;p<0.001)intheKMnO4-petroleumjellygroup.Seven
days after treatment, signs of local inflammationhad sig-nificantly decreasedinthe dimeticonegroup(p<0.001),but not in the KMnO4-petroleum jelly group. The little effect
observedafterbathingthefootinKMnO4 wasattributedto
liquidandmayhavepartiallysealedtheabdominalconewhen KMnO4haddied.
The finding that the local inflammation rapidly disap-peared when the parasite had died in situ showed that inflammationiscausallyrelatedtothepresenceofaviable parasite. In practice, this means that there is no need to surgicallyremoveembeddedparasitesaftertreatmentwith NYDA®: the deadparasites are eliminatedbynatural skin repairmechanismwithoutdelay(H.Feldmeier,unpublished observation,2016).
In astudy in rural Uganda, the efficacy oftwo distinct modesofapplicationofNYDA® werecompared:onetargeted applicationtotheareawheretheparasiteprotrudesthrough theskinandonecomprehensiveapplicationtothewholefoot, identical tothe oneused inthe proof-of-principle-study.26
Wholefoottreatmentmeantthatdimeticonewasappliedto theskinofthefootuptotheankle.Targetedtreatmentmeant that dimeticonewas aspired into a 5-mLsyringe towhich aflexible tube was mounted.Three drops were applied to theareawheretheparasite’srearabdominalconeprotruded throughtheskin. Onedropcorrespondedtoapproximately 50Lofdimeticone.Thisprocedurewasrepeatedthreetimes within10mintoensurethatamaximumamountof dimeti-coneentered the rear abdominalcone ofthe parasite and sealedit.
Atthefirstfollow-up,twodaysaftertreatment,thenumber ofviableparasitesdecreasedsignificantlyinbothgroups.The lossofviabilitywashigherinthetargetedtreatmentgroup (p<0.001).Atthesecondfollow-up,afterfivedays,thelossof viabilitywasstillhigherinthetargetedtreatmentgroup com-paredtothewholefoottreatmentgroup(p<0.02).Afterseven days,thereductionofthenumberofviablesandfleaswas similarinbothgroups:95%(95%CI92–99%)oftheparasitesin thewholefoottreatmentgrouphadlostallsignsofviability and97%(95%CI94–99%)inthetargetedtreatmentgroup.The authorsconcludedthatthetargetedapplicationkilled embed-dedsand fleas morerapidly compared towhen the whole footwascovered.Besides,substantiallylessdimeticonewas needed.26
In a case series of patients with very severe tungiasis in Vaupés Department, Colombia, five patients being in a life-threateningconditionwereidentifiedinAmerindian com-munities.All patientsshowedhundreds(uptoathousand) embedded sand fleas and presented ectopic localizations ofembedded sand fleas suchas at the ankles, the knees, the elbows,the fingersand around the anus.Atthe soles, embedded sand fleas were laying in multiple layers on top of each other.10 All affected body areas with
embed-ded sand fleas were intensely wetted with NYDA® and treatment was repeated after 12–24h. All patients recov-ered rapidly. After three to four days, inflammation of the skin had regressed considerably, and patients could place their feet on the ground without feeling pain. After one week all lesions had developed into crusts and heal-ing of the skin had started.10 No adverse events were observed.10
Animportant finding ofthe three studies was that the fewparasiteswhichremainedviabledidnotexpeleggs.This suggeststhatasystematicapplicationofNYDA® onthe com-munitylevelmayresultinatotaldisruptionoftheoff-host
cycle–providedthatthereisnoanimalreservoirinvolvedin maintenanceofthecycle.
Takentogetherthethreestudiesprovideevidencethat: • NYDA® killsup to97% ofembeddedsandfleas within5
days;
• Atargetedapplicationactsmorerapidlythanwettingthe wholefoot andneeds considerablyless dimeticone.This makesthetargetedapplicationmorecost-effectiveif the totalnumberoflesionsis<40orifpenetratedsandfleasare locatedinclusters;
• NYDA® is effective in infections with several hundred embeddedsandfleassituatedinexcessivehyper-keratotic skinandlocatedontopofeachother.Inthesecases,the affectedskinhastobewettedintensivelyandrepeatedly withNYDA®.
Otherectoparasites
During a study on scabies in indigenous communities in the Amazon lowlandofColombia,several individuals were identifiedhavingmyiasiscausedbyDermatobiahominis.The infectionwassuccessfullytreatedbythetopicalapplication ofNYDA® (HollmanMiller,unpublishedobservation,2018).
Safety
of
dimeticones
Generalaspects
Dimeticonesarewidelyusedincosmeticsandindustrialfood preparation.Dimeticonesareusedinurology,ophthalmology anddermatology.27IntheEuropeanUnion(EU),high-viscous
dimeticonesareapprovedasantifoamingfoodadditive‘E900’ atamaximumlevelof10mg/kginsolidfoodstuffsand10mg/L inliquids.Theacceptabledailyintakeis1.5mg/kgof body-weight.
NYDA® isaCEmarkedclassIIamedicaldeviceregistered fortreatmentofectoparasites.NYDA® fallsinEUregulatory classIIaaccordingtoRule4,AnnexIXoftheCouncil Direc-tive93/42/EECof14June1993concerningmedicaldevices,as amendedbyDirective2007/47/EC.NYDA® isavailableonthe marketsince2006.19
High-viscousdimeticones
High-viscous dimeticones are of well-established use in humansregardingtopicalandoraladministration(suchasin cosmeticsanddrugs,particularlyindrugstotreatflatulence) indosesexceedinglargerthanthoseappliedinNYDA® forthe treatmentofpediculosiscapitis.
In2011,theEuropeanCentreforEcotoxicologyand Toxicol-ogyofChemicalsJointAssessmentofCommodityChemicals (JACC)27 concluded that humans may be exposed to
high-viscousdimeticonesviaoralordermalcontactwithoutany healthrisk(IASONConsulting,2016,unpublisheddocument). Inlaboratoryanimals,thesubstancesshowedalowpotential forabsorptionbytheseroutes.Sincedimeticonesare metabol-ically inert, following ingestion, they are rapidly excreted unchangedinthefeces.27
Inrabbits,noteratogeniceffectswerefoundafter implan-tation as well as after oral administration. None of the reproductiveand developmental toxicitystudiesperformed using rats and rabbits gaveevidence ofany adverse effect ofhigh-viscous dimeticones on fertility, gestation,peri- or post-natal development after oral, dermal or implantation exposure.27
Insummary,animal studydataaswellasclinical expe-rienceinhumansshowedthathigh-viscousdimeticonesare highlyunlikelytobeabsorbedatsignificantamountsbythe humanbodyirrespectiveoftherouteofapplication(dermal, oral,inhalation).Theriskofembryotoxicity,fetotoxicity, ter-atogenicity,oranysystemictoxicityinthefetus,breast-fed babyorchildren≤2yearsofageisjudgedasvirtually non-existent(IASONConsulting,2016,unpublisheddocument).
Takentogether,fromthetoxicologicalpointofview,there arenoobjectionstousehigh-viscousdimeticonesforthe topi-caltreatmentofectoparasitesinpregnantorlactatingwomen aswellasinchildren≤2yearsofage(IASONConsulting,2016, unpublisheddocument).
Low-viscousdimeticones
Low-viscousdimeticonesarehighlyvolatilesubstancesthat are potentially absorbed afterinhalationbut pass the skin onlyatlowamounts.Animaltoxicitydataonthelow-viscous dimeticonesoctamethyltrisiloxane,decamethyltetrasiloxane and hexadimethylsiloxane revealed no evidence of any detrimental effect on reproductive or developmental per-formance up to the highest doses tested after inhalation exposure (IASON Consulting, 2016, unpublished). As these low-viscousdimeticones aretransferredinto humanbreast milkonly at trace amounts, the risk of adverse effects to thebreast-fedbabycanalsobeconsiderednegligiblylow.A toxicologicalreview concludedthat the risk of embryotox-icity, fetotoxicity,teratogenicity,orany systemictoxicity in the fetus, breast-fedbaby or children≤2 years ofage can bejudgedasverylow(IASONConsulting,2016,unpublished document).
Inflammability
Since dimeticones contain oxygen, they are potentially inflammable. Their inflammability depends on the chain length of the molecule. Dimeticones with a short chain, havealowviscosityand ahighvolatilityandthereforeare inflammableatratherlowtemperatures.Incontrast, dimeti-coneswithmediumtolongchainarenotvolatileandneed hightemperaturestogetignited.
Experiments performed under standardized conditions showedthathumanhairimpregnatedwithNYDA® cannot beeasilyignitedbutneedsadirectcontacttoanakedflame. AssumingthatscalphaircoveredwithNYDA® mightfunction asawickenhancingtheinflammability,andfurthermorehair increasesthesurfaceincontactwithoxygen,therisktocatch fireonhumanskinwasconsideredverylow.Nonetheless,it isrecommendedbytheproducerthataftertopicaltreatment withNYDA® directcontacttonakedflamesisavoidedfor2h (Pohl-Boskamp,unpublisheddocument,2012).
Clinicalstudies
SafetyofNYDA® inthetreatmentofheadliceinfestation
Arandomizedcontrolledtrialinchildrenwithheadlice infes-tationsshowedthatNYDA® canbeconsideredasverysafe. ExceptintwocasesinwhichNYDA® accidentallycamein touchwiththeeyeandresultedinatemporaryirritationof theconjunctiva,noadverseeventsoccurred.23
SafetyofNYDA® inthetreatmentoftungiasis
In contrast to ectoparasites such as lice and other siphonaptera species, sand fleas are embedded almost completely in the epidermis. To determine whether topi-cally applied dimeticone can penetrate into the skin next toa lesion,aseriesofexperiments wasperformedin nat-urally infected pigs in rural Uganda (Mutebi et al., 2018, unpublished). Five drops of NYDA® were applied on the rear abdominal cone of the embedded sand fleas on the digitsofthepigs.Aftertreatment,embeddedsandfleaswere surgically removed and were examined using a handheld light microscope to establish if the dimeticone had crept betweenthecuticleoftheparasiteandthehosttissues.After treatmentwithNYDA® nodimeticonewasdetectedonthe outersurfaceoftheembeddedsandfleasandintheadjacent host tissue. The outer surface of the intersegmental skin remainedwhitishasitisnormallythecase.
Intworandomizedcontrolledtrialswithatotalof106 par-ticipants,notasingleadverseeventwasobserved,evenwhen thewholefootwasrepeatedlycoveredwithNYDA®.15,26
More-over,patientslikedtheapplicationofthedimeticone,because itsoftenedroughanddryskinandgaveitanappealingshine.15
Discussion
Dimeticonesarepolymersiliconeoilsandhaveapure phys-ical mode of action on ectoparasites. Due to the physical modeofactiondevelopmentofresistanceishighlyunlikely. Althoughwedonotrestrictthedocumentsanalyzedbystudy population, type ofintervention, outcome measures, dura-tionoffollow-upandlanguage,wefoundalimitednumber ofpublicationsandgrayliteratureonefficacy andsafetyof dimeticonesforthetreatmentofparasiticskindiseasesinour search.However,withtheavailableevidence,wecanconclude thatdimeticonesareverysafemoleculesandcanbeused top-icallyeveninsmallchildrenandpregnantwomen.NYDA®, amixtureoftwodimeticoneswithadifferentviscosityand volatility,hasbeenshowntobeeffectiveinpediculosiscapitis, pediculosispubis,tungiasis,andmyiasis.
Dimeticones are promising tools for the treatment of parasites residing on top or inside the skin, provided the dimeticoneisabletotargettheAchillesheelofthe respec-tiveparasite,suchastherespiratorytractinliceandtherear abdominalconeinsandfleas.
Tungiasis,likeotherparasiticskindiseases,continuesto affect the quality of life of many people, especially those fromruralareas,withlimitedaccesstohealthservicesand lowincome.Thedevelopmentofresearchonprevalence, dis-easeburden,complicationsassociatedwithhighinfestation andbadtherapeuticpracticesinthecommunity,toxicityor
adverse effects when dimeticones and NYDA are used on bleedingskinorskinthathaslacerationsaswellasthe devel-opmentofnewtreatmentsandtheevaluationoftheefficacy andsafetyofthosealreadyavailable,isawayof contribut-ingtothereductionofunfairinequalitiesinhealththatexist betweenthesepopulationsandthemajoritysocieties. There-fore, their study and dissemination ofthe resultsthrough scientificpublicationsshouldbepartoftheresearchand pub-lichealthagendasofthegovernmentsofendemiccountries andcollaboratingcenters.
Conflicts
of
interest
Theauthorsdeclarenoconflictsofinterest.
r
e
f
e
r
e
n
c
e
s
1. FeldmeierH,HeukelbachJ,UgbomoikoUS,etal.Neglected diseasewithmanychallengesforglobalpublichealth.PLoS NeglTropDis[Internet].2014;8:1–8.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4214674/
[cited10.12.19].
2. Chinchilla-Casta ˜nedaK,Domínguez-MillánRA, Domínguez-ZambranoA,Mercadillo-PérezP.Tungiasis. DermatolRevMex[Internet].2016;60:59–65.
https://www.medigraphic.com/pdfs/derrevmex/rmd-2016/ rmd161j.pdf[cited10.12.19].
3. MillerH,RodríguezG.TungiasisinnativeAmerindiansin Vaupésprovince:epidemiology,clinicalaspects,treatment, andprevention.Biomédica[Internet].2010;30:215–37.
https://www.revistabiomedica.org/index.php/biomedica/ article/view/185[cited11.08.19].
4. ChadeeDD.Tungiasisamongfivecommunities south-westernTrinidad,inWestIndies.AnnTropMed Parasitol[Internet].1998;92:107–13[cited10.12.19].
5. HeukelbachJ.Invitedreviewtungiasis.RevInstMedTropS Paulo[Internet].2005;47:307–13.
https://www.ncbi.nlm.nih.gov/pubmed/16553319
6. ArizaL,SeidenschwangM,BuckendahlJ,GomideM, FeldmeierH,HeukelbachJ.Tungíase:doenc¸anegligenciada causandopatologiagraveemumafaveladeFortaleza,Ceará. RevSocBrasMedTrop[Internet].2007;40:63–7.
http://www.scielo.br/scielo.php?script=sciabstract&pid=S0037 -86822007000100013&lng=en&nrm=iso&tlng=pt[cited 10.12.19].
7. deCarvalhoRW,deAlmeidaAB,Barbosa-SilvaSC,AmorimM, RibeiroPC,Serra-FreireNM.Thepatternsoftungiasisin Araruamatownship,stateofRiode
Janeiro,Brazil.MemInstOswaldoCruz[Internet].2003;98:31–6.
http://www.scielo.br/scielo.php?script=sciabstract&pid=S0074 -02762003000100005&lng=en&nrm=iso&tlng=en[cited 11.08.19].
8. Ibá ˜nez-BernalS,Velasco-CastrejónO.Newrecordsofhuman tungiasisinMexico(Siphonaptera:Tungidae).JMedEntomol [Internet].1996;33:988–9.
https://academic.oup.com/jme/article/33/6/988/899047[cited 11.08.19].
9. LinardiPM,CalheirosCML,Campelo-JuniorEB,DuarteEM, HeukelbachJ,FeldmeierH.Occurrenceoftheoff-hostlife stagesofTungapenetrans(Siphonaptera)invarious environmentsinBrazil.AnnTropMedParasitol[Internet]. 2010;104:337–45[cited11.08.19].
10.MillerH,Trujillo-TrujilloJ,FeldmeierH.Veryseveretungiasis inAmerindiansintheAmazonlowlandofColombia:acase
series.PLoSNeglTropDis[Internet].2019;13:1–19,e0007068.
https://journals.plos.org/plosntds/article?id=10.1371/journal .pntd.0007068[cited11.08.19].
11.EiseleM,HeukelbachJ,VanMarckE,etal.Investigationson thebiology,epidemiology,pathologyandcontrolofTunga penetransinBrazil:I.Naturalhistoryoftungiasisinman. ParasitolRes[Internet].2003;90:
87–99[cited11.08.19].
12.FeldmeierH,HeukelbachJ,EiseleM,SousaAQ,BarbosaLMM, CarvalhoCBM.Bacterialsuperinfectioninhumantungiasis. TropMedIntHealth[Internet].2002;7:559–64[cited11.08.19].
13.JosephJK,BazileJ,MutterJ,etal.TungiasisinruralHaiti:a community-basedresponse.TransRSocTropMedHyg [Internet].2006;100:970–4.
https://academic.oup.com/trstmh/article/100/10/970/1913208
[cited11.08.19].
14.NgunjiriJ,KeiyoroPN,MwandaW.Quantifyingburdenof diseasecausedbyTungiasisusingdisabilityadjustedlife yearsmetricamongthechildrenaged5–14yearsinMuranga Country,Kenya.IntResJPublicEnvironHealth[Internet]. 2015;2:152–8.
https://journalissues.org/wp-content/uploads/2015/10/Ngunjiri-et-al.pdf[cited02.09.19]. 15.ThieleckeM,NordinP,NgomiN,FeldmeierH.Treatmentof
Tungiasiswithdimeticone:aproof-of-principlestudyinrural Kenya.PLoSNeglTropDis[Internet].2014;8:1–10,e3058.
https://journals.plos.org/plosntds/article?id=10.1371/journal .pntd.0003058
16.HeukelbachJ,EiseleM,JacksonA,FeldmeierH.Topical treatmentoftungiasis:arandomized,controlledtrial.Ann TropMedParasitol[Internet].2003;97:743–9[cited11.08.19].
17.HeukelbachJ,FranckS,FeldmeierH.HighattackrateofTunga penetrans(Linnaeus1758)infestationinanimpoverished Braziliancommunity.TransRSocTropMedHyg[Internet]. 2004;98:
431–4.
https://academic.oup.com/trstmh/article/98/7/431/1887488
[cited11.08.19].
18.BurgessIF.Themodeofactionofdimeticone4%lotion againstheadlice,Pediculuscapitis.BMCPharmacol[Internet]. 2009;9:1–8.http://link.springer.com/10.1186/1471-2210-9-3
[cited24.08.19].
19.GorathM.Nyda.Berlin,Heidelberg:Springer-Verlag[Internet]; 2010.https://www.springer.com/de/book/9783642146305
[cited02.09.19].
20.RichlingI,BöckeierW.Lethaleffectsoftreatmentwitha specialdimeticoneformulaonheadliceandhousecrickets (Orthoptera,Ensifera:AchetadomesticaandAnoplura, Phthiraptera:Pediculushumanus).Arzneimittelforschung [Internet].2008;58:248–54.http://www.thieme-connect.de/ DOI/DOI?10.1055/s-0031-1296501[cited11.08.19].
21.FAO.PolydimethylsiloxaneINSNo.900a-JECFA Standards-International-FoodLaws&
Regulations-Documents-GlobalFoodMate[Internet];2013.
http://files.foodmate.com/2013/files2358.html[cited 02.09.19].
22.NairB.Finalreportonthesafetyassessmentofstearoxy dimethicone,dimethicone,methicone,aminobispropyl dimethicone,aminopropyldimethicone,amodimethicone, amodimethiconehydroxystearate,behenoxydimethicone, C24-28alkylmethicone,C30-45alkylmethicone,C30-45alkyl dimethicone,cetearylmethicone,cetyldimethicone, dimethoxysilylethylenediaminopropyldimethicone,hexyl methicone,hydroxypropyldimethicone,stearamidopropyl dimethicone,stearyldimethicone,stearylmethicone,and vinyldimethicone.IntJToxicol[Internet].2003;22Suppl.2: 11–35.http://europepmc.org/abstract/med/14555417[cited 11.08.19].
23.HeukelbachJ,PilgerD,OliveiraFA,KhakbanA,ArizaL, FeldmeierH.Ahighlyefficaciouspediculicidebasedon dimeticone:randomizedobserverblindedcomparativetrial. BMCInfectDis[Internet].2008;8:1–10[cited11.08.19].
24.HeukelbachJ,SonnbergS,BecherH,MeloI,SpeareR,Oliveira FA.Highovicidalefficacyofdimeticone:aneweraofhead licetreatment.JAmAcadDermatol[Internet].2011;64:61–2 [cited11.08.19].
25.StrycharzJP,LaoAR,AlvesA-M,ClarkJM.Ovicidalresponseof NYDAformulationsonthehumanheadlouse(Anoplura: Pediculidae)usingahairtuftbioassay.JMedEntomol [Internet].2012;49:336–42.
https://academic.oup.com/jme/article/49/2/336/905823[cited
11.08.19].
26.NordinP,ThieleckeM,NgomiN,MudangaGM,KrantzI, FeldmeierH.Treatmentoftungiasiswithatwo-component dimeticone:acomparisonbetweenmoisteningthewhole footanddirectlytargetingtheembeddedsandfleas.Trop MedHealth[Internet].2017;45:6[cited11.08.19].
27.ECETOCpublishesJointAssessmentofCommodity Chemicals(JACC)ReportNo.55onLinear
Polydimethylsiloxanes[Internet].Ecetoc[cited11.08.19].
http://www.ecetoc.org/mediaroom/ecetoc-publishes-joint- assessment-of-commodity-chemicals-jacc-report-no-55-on-linear-polydimethylsiloxanes/.